This inventor holds 1 USPTO granted patent. Top assignees: Riken Corporation, Sysmex Corporation, The Jikei University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 892 
1 out of 1,056 
1 out of 8 Years Active: 2022
Title: The Innovations of Takahiro Masaki
Introduction
Takahiro Masaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical research and therapeutic applications.
Latest Patents
One of Takahiro Masaki's notable patents is titled "Antibody against human TGF-β LAP degradate." This patent discloses an isolated monoclonal antibody that targets a human Transforming Growth Factor-β (TGF-β) Latency Associated Protein (LAP) degradate. The antibody is capable of recognizing an integrin binding site in the human TGF-β LAP degradate, showcasing its potential for various medical applications. He holds 1 patent.
Career Highlights
Throughout his career, Takahiro Masaki has worked with esteemed organizations such as Riken Corporation and The Jikei University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Takahiro has collaborated with notable colleagues, including Ikuyo Inoue and Soichi Kojima. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Takahiro Masaki's contributions to biotechnology, particularly through his patent on monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile